291 related articles for article (PubMed ID: 8917700)
1. Immunoreactivity and pharmacokinetics of horse anti-scorpion venom F(ab')2-scorpion venom interactions.
Pépin-Covatta S; Lutsch C; Grandgeorge M; Lang J; Scherrmann JM
Toxicol Appl Pharmacol; 1996 Nov; 141(1):272-7. PubMed ID: 8917700
[TBL] [Abstract][Full Text] [Related]
2. Interspecies scaling of clearance and volume of distribution for horse antivenom F(ab')2.
Bazin-Redureau M; Pepin S; Hong G; Debray M; Scherrmann JM
Toxicol Appl Pharmacol; 1998 Jun; 150(2):295-300. PubMed ID: 9653060
[TBL] [Abstract][Full Text] [Related]
3. Initial volume of a drug before it reaches the volume of distribution: pharmacokinetics of F(ab')2 antivenoms and other drugs.
Sevcik C; Salazar V; Díaz P; D'Suze G
Toxicon; 2007 Oct; 50(5):653-65. PubMed ID: 17689580
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of a F(ab')2 scorpion antivenom administered intramuscularly in healthy human volunteers.
Vázquez H; Chávez-Haro A; García-Ubbelohde W; Paniagua-Solís J; Alagón A; Sevcik C
Int Immunopharmacol; 2010 Nov; 10(11):1318-24. PubMed ID: 20849955
[TBL] [Abstract][Full Text] [Related]
5. Toxicokinetic and toxicodynamic analyses of Androctonus australis hector venom in rats: optimization of antivenom therapy.
Hammoudi-Triki D; Lefort J; Rougeot C; Robbe-Vincent A; Bon C; Laraba-Djebari F; Choumet V
Toxicol Appl Pharmacol; 2007 Feb; 218(3):205-14. PubMed ID: 17198719
[TBL] [Abstract][Full Text] [Related]
6. Preclinical assessment of immunoreactivity of a new purified equine F(ab')2 against European viper venom.
Pepin-Covatta S; Lutsch C; Lang J; Scherrmann JM
J Pharm Sci; 1998 Feb; 87(2):221-5. PubMed ID: 9519157
[TBL] [Abstract][Full Text] [Related]
7. Mortality and antibody responses of mice to three successive episodes of experimental scorpion (Centruroides limpidus limpidus) envenomation and immunological rescue.
Padilla A; Govezensky T; Possani LD; Larralde C
Toxicon; 2005 Aug; 46(2):142-9. PubMed ID: 15946719
[TBL] [Abstract][Full Text] [Related]
8. Modelling Tityus scorpion venom and antivenom pharmacokinetics. Evidence of active immunoglobulin G's F(ab')2 extrusion mechanism from blood to tissues.
Sevcik C; D'Suze G; Díaz P; Salazar V; Hidalgo C; Azpúrua H; Bracho N
Toxicon; 2004 Dec; 44(7):731-41. PubMed ID: 15500849
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of a F(ab')2 scorpion antivenom in healthy human volunteers.
Vázquez H; Chávez-Haro A; García-Ubbelohde W; Mancilla-Nava R; Paniagua-Solís J; Alagón A; Sevcik C
Toxicon; 2005 Dec; 46(7):797-805. PubMed ID: 16197974
[TBL] [Abstract][Full Text] [Related]
10. Snake F(ab')2 antivenom from hyperimmunized horse: pharmacokinetics following intravenous and intramuscular administrations in rabbits.
Pepin S; Lutsch C; Grandgeorge M; Scherrmann JM
Pharm Res; 1995 Oct; 12(10):1470-3. PubMed ID: 8584483
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of 125I-labelled Walterinnesia aegyptia venom and its distribution of the venom and its toxin versus slow absorption and distribution of IGG, F(AB')2 and F(AB) of the antivenin.
Ismail M; Abd-Elsalam MA; Al-Ahaidib MS
Toxicon; 1998 Jan; 36(1):93-114. PubMed ID: 9604285
[TBL] [Abstract][Full Text] [Related]
12. Absorption and elimination of viper venom after antivenom administration.
Rivière G; Choumet V; Saliou B; Debray M; Bon C
J Pharmacol Exp Ther; 1998 May; 285(2):490-5. PubMed ID: 9580588
[TBL] [Abstract][Full Text] [Related]
13. Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy.
Rivière G; Choumet V; Audebert F; Sabouraud A; Debray M; Scherrmann JM; Bon C
J Pharmacol Exp Ther; 1997 Apr; 281(1):1-8. PubMed ID: 9103473
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic studies of scorpion venom before and after antivenom immunotherapy.
Krifi MN; Savin S; Debray M; Bon C; El Ayeb M; Choumet V
Toxicon; 2005 Feb; 45(2):187-98. PubMed ID: 15626368
[TBL] [Abstract][Full Text] [Related]
15. Antivenom for critically ill children with neurotoxicity from scorpion stings.
Boyer LV; Theodorou AA; Berg RA; Mallie J; ; Chávez-Méndez A; García-Ubbelohde W; Hardiman S; Alagón A
N Engl J Med; 2009 May; 360(20):2090-8. PubMed ID: 19439743
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of cardio-respiratory perturbations following Mesobuthus eupeus envenomation in anesthetized rabbits with commercial polyvalent F(ab')2 antivenom.
Zayerzadeh E; Koohi MK; Mirakabadi AZ; Fardipoor A; Kassaian SE; Rabbani S; Anvari MS
Toxicon; 2012 Feb; 59(2):249-56. PubMed ID: 22118980
[TBL] [Abstract][Full Text] [Related]
17. Preparation of F(ab')
Ismael BN; Abass KS; Khalil KA; Salih KA
Biologicals; 2018 Nov; 56():19-23. PubMed ID: 30153952
[TBL] [Abstract][Full Text] [Related]
18. Effects of antivenom on Buthus occitanus tunetanus (Bot) scorpion venom pharmacokinetics: towards an optimization of antivenom immunotherapy in a rabbit model.
Krifi MN; Miled K; Abderrazek M; El Ayeb M
Toxicon; 2001 Sep; 39(9):1317-26. PubMed ID: 11384719
[TBL] [Abstract][Full Text] [Related]
19. Production of anti-horse antibodies induced by IgG, F(ab')2 and Fab applied repeatedly to rabbits. Effect on antivenom pharmacokinetics.
Vázquez H; Olvera F; Alagón A; Sevcik C
Toxicon; 2013 Dec; 76():362-9. PubMed ID: 24047962
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of 125I-labelled IgG, F(ab')2 and Fab fractions of scorpion and snake antivenins: merits and potential for therapeutic use.
Ismail M; Abd-Elsalam MA
Toxicon; 1998 Nov; 36(11):1523-8. PubMed ID: 9792168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
